This content is machine translated Multiple Myeloma “Myeloma therapy has made great strides in recent years” In an interview with InFo ONCOLOGY & HEMATOLOGY, Prof. Christoph Renner, MD, Onkozentrum Hirslanden, Zurich, discusses the latest therapeutic advances in multiple myeloma. In doing so, he answers questions such…
View Post 4 min This content is machine translated Pathological scars - pathogenesis, diagnosis and treatment “There are no quick therapy successes in the treatment of scars” Severin Läuchli, MD, senior physician and head of dermatosurgery at the Dermatology Clinic at the USZ, discussed the development and therapy of pathological scars with DERMATOLOGIE PRAXIS. From a broad…
View Post 4 min This content is machine translated Warts Treatment must not be suspended too early In an interview with DERMATOLOGIE PRAXIS, Med. pract. Daniel Fleisch, Dermatologisches Ambulatorium Triemli, on the etiology and the numerous ways warts can be treated. It provides information on when therapy…
View Post 3 min This content is machine translated Dysphagia “The most threatening complication is aspiration”. Jochen Rosenfeld, MD, Head of the Department of Hearing, Speech and Voice Medicine at the Ear, Nose and Throat Clinic, Cantonal Hospital St. Gallen, answers questions about dysphagia in an…
View Post 3 min This content is machine translated Edwards SAPIEN 3 How does the new generation perform in practice? With CARDIOVASC, PD Patrick Diemert, MD, of the University Heart Center Hamburg, Germany, discussed the advantages of Edwards’ new generation of TAVI heart valves. He discussed the advances over older…
View Post 4 min This content is machine translated Chronic pain patients It needs leadership, eminence and effective medicines About ten percent of the Swiss population suffers from chronic pain. Monika Jaquenod-Linder, MD, has been a pain therapist in Zurich for about twenty years. At the Spine and Pain…
View Post 4 min This content is machine translated Allergic contact dermatitis in Europe “The psychological component of the disease is often underestimated” In an interview with DERMATOLOGIE PRAXIS, Prof. Dr. med. Peter Elsner, Director of the Clinic for Dermatological Diseases at the University Hospital Jena, provides information on the epidemiology of allergic…
View Post 4 min This content is machine translated Fall prevention “Falls cause immense follow-up costs – prevention is therefore urgently needed” In an interview with HAUSARZT PRAXIS, Barbara Zindel, dipl. Physiotherapist FH, Rheumaliga Schweiz, the project “Living mobile and safe at home”. The pilot phase in Lucerne has been a success…
View Post 4 min This content is machine translated Interview on the ACC/AHA guidelines Lipid treatment recommendation meets with little approval Statins continue to be the drug of choice for LDL-C therapy, although not all patients achieve their target levels with therapy alone. However, the paradigm shift implemented in the new…
View Post 3 min This content is machine translated CLL11 study Combination of chlorambucil and CD20 antibody the new standard as early as 2014? In an interview with InFo ONCOLOGY & HEMATOLOGY, Michael Gregor, MD, of Lucerne Cantonal Hospital, talks about the CLL11 trial. It addresses the study population, the most relevant results, and…
View Post 4 min This content is machine translated Infectiology When are the antiviral drugs used? In an interview with HAUSARZT PRAXIS, Prof. Dr. med. Hansjakob Furrer from the University Clinic for Infectiology at the Inselspital Bern provides information on the subject of colds and flu.…
